{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:27:37Z","timestamp":1762543657114},"reference-count":15,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OPTH"],"DOI":"10.2147\/opth.s361146","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T02:29:12Z","timestamp":1655692152000},"page":"1985-1992","source":"Crossref","is-referenced-by-count":4,"title":["Real-World Experience with Intracapsular Administration of Dexamethasone Intraocular Suspension 9% for Control of Postoperative Inflammation"],"prefix":"10.2147","volume":"Volume 16","author":[{"given":"Cathleen","family":"McCabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Nijm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Osher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00055735-200002000-00002","volume":"11","author":"McColgin","year":"2000","journal-title":"Curr Opin Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/ICU.0000000000000625","volume":"31","author":"Shorstein","year":"2020","journal-title":"Curr Opin Ophthalmol"},{"key":"ref3","first-page":"S215","volume":"25","author":"Salinger","year":"2019","journal-title":"Am J Manag Care"},{"key":"ref4","unstructured":"DEXYCU\u00ae (dexamethasone intraocular suspension) 9% full US. Prescribing information; 2020."},{"key":"ref5","unstructured":"Wong VG, White WS, Hu MW, Huang GT, Karasina F. Use of sustained release dexamethasone in post-cataract surgery inflammation. US patent application 14\/893,381. 2016 May 5."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ophtha.2017.12.029","volume":"125","author":"Donnenfeld","year":"2018","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jcrs.2018.07.015","volume":"44","author":"Donnenfeld","year":"2018","journal-title":"J Cataract Refract Surg"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/j.jcrs.0000000000000363","volume":"47","author":"Matossian","year":"2021","journal-title":"J Cataract Refract Surg"},{"key":"ref9","unstructured":"Hovanesian J, Donnenfeld E. The D3 Study: drug delivery vs drops\u2014a prospective clinical study evaluating Dexycu vs prednisolone acetate 1% in controlling post-operative pain and inflammation in patients undergoing sequential cataract surgery. Presented at: The American Academy of Ophthalmology Meeting (virtual); November 13\u201315; 2020."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e000491","DOI":"10.1136\/bmjophth-2020-000491","volume":"5","author":"Kiernan","year":"2020","journal-title":"BMJ Open Ophthalmol"},{"key":"ref11","unstructured":"Weinstock RJ. Dexamethasone intraocular suspension 9% after cataract surgery: data from a retrospective study. Presented at: The American Academy of Ophthalmology Annual Meeting; November 13\u201315; 2020; virtual."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1097\/j.jcrs.0000000000000458","volume":"47","author":"Osher","year":"2021","journal-title":"J Cataract Refract Surg"},{"key":"ref13","unstructured":"Tan NE, Radcliffe N. Outcomes of dexamethasone intraocular suspension during cataract surgery and concomitant cataract-micro-invasive glaucoma surgery (MIGS). Presented at: The Association for Research in Vision and Ophthalmology Annual Meeting; 2020."},{"key":"ref14","first-page":"3433","volume":"62","author":"Hanson","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref15","unstructured":"Matossian C. Outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative antiinflammatory medications. Presented at: The American Academy of Ophthalmology Annual Meeting (virtual); November 13\u201315; 2020; virtual."}],"container-title":["Clinical Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=81583","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=81583","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T02:29:19Z","timestamp":1655692159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/real-world-experience-with-intracapsular-administration-of-dexamethaso-peer-reviewed-fulltext-article-OPTH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":15,"URL":"https:\/\/doi.org\/10.2147\/opth.s361146","relation":{},"ISSN":["1177-5483"],"issn-type":[{"value":"1177-5483","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}